DENTSPLY SIRONA Inc.
No SEC Form 4 filings for $XRAY in the last 30 days.
Dentsply Sirona announced its participation in the 2026 Stifel Jaws & Paws Conference, with management scheduled to present on May 27, 2026, at 3:35 p.m. ET. A live audio webcast and replay will be available on the company's investor relations website. Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies.
Dentsply Sirona reported its Q1 2026 financial results, with net sales of $880 million and an adjusted EPS of $0.27, reiterating its full-year 2026 outlook. The company is actively executing its Return-to-Growth Action Plan, including the launch of AI-enabled diagnostic aids and expansion of distribution agreements, despite facing near-term external pressures.
Vanguard Capital Management has reported beneficial ownership of 10,529,427 shares of Dentsply Sirona (NASDAQ: XRAY), representing 5.27% of the common stock. This disclosure was made in a Schedule 13G filing on April 29, 2026. The filing indicates Vanguard has sole voting power over 1,529,870 shares and sole dispositive power over all 10,529,427 shares, signifying a passive investment stake.
